MODULATING LACTOGENIC ACTIVITY IN MAMMALIAN CELLS

PRODUCTS FOR CELL CONVERSION

COMPOSITIONS AND METHODS FOR TREATING CHRONIC PAIN AND FOR RETROGRADE TRANSDUCTION OF NEURONS

COMPOSITION FOR WOUND TREATMENT COMPRISING STEM CELL-DERIVED EXTRACELLULAR VESICLES WITH ENHANCED EFFICACY

CATIONIC LIPIDS CONTAINING SILICON

ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE

COMPOSITIONS AND METHODS RELATED TO MULTIPLE MYELOMA-ASSOCIATED LONG NONCODING RNAS

INHIBITORS OF MIR-221 FOR THE TREATMENT OF SOLID NEOPLASMS AND PERIPHERAL NEUROTOXICITY INDUCED BY ANTICANCER DRUGS AND OTHER NEUROLOGICAL DISEASES RELATED TO MIR-221

LPA inhibitors and uses thereof

GENOME EDITING IN PLANTS

MUSCLE-TARGETING COMPLEXES AND USES THEREOF

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)

SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TOPICAL PATCH COMPOSITION FOR TARGETED SIRNA NANOPLEX DELIVERY AND GENE THERAPIES AND METHOD OF MAKING AND USE THEREOF

COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING LIPID NANOPARTICLES

TOEHOLD EXCHANGE RIBOREGULATOR GATE AND REGULATING PROTEIN TRANSLATION WITH TOEHOLD EXCHANGE RIBOREGULATOR

SYNTHESIS AND STORAGE OF DNA HAVING ATTACHED NANOSTRUCTURE

Methods for Suppression of Gene Silencing in Plants

TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT

BIS-RNAI COMPOUNDS FOR CNS DELIVERY

COMPOSITION AND METHOD FOR TREATING LUNG DISEASES

COMPOUNDS AND METHODS FOR MODULATING SCN2A

ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES

Selective Antisense Compounds and Uses Thereof

STABILIZATION OF THERAPEUTIC TRANS-SPLICING RNA MOLECULES IN HUMAN CELLS

TARGETED INHIBITION OF REVERSE TRANSCRIPTION USING ANTISENSE OLIGOS

MICRORNA SYSTEM

Cyclic Structured Oligonucleotides as Therapeutic Agents

MSI2 AS A THERAPEUTIC TARGET FOR THE TREATMENT OF MYOTONIC DYSTROPHY

COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES

TRANS-SPLICING RIBOZYME SPECIFIC TO APOE4 RNA AND USE THEREOF

INCORPORATION OF UNNATURAL NUCLEOTIDES AND METHODS THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS

NUCLEIC ACID DELIVERY SYSTEM

Olfactory Delivery Scaffolds Using Antisense Oligonucleotides and Methods for Making and Using Same

METHODS FOR THE IDENTIFICATION AND TREATMENT OF SEVERE FORMS OF COVID-19

Linkage Modified Oligomeric Compounds

RNAI AGENTS TARGETING CIDEB AND RELATED METHODS

COMPOSITIONS AND METHODS FOR MODULATING APOC3 EXPRESSION

METHOD OF TREATING, AMELIORATING AND/OR PREVENTING POLYCYSTIC KIDNEY DISEASE

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH siRNAS TARGETING TBX3

EXOSOME THERAPY AND PROCESS TO IMPROVE FORMULATION AND PRODUCTION

COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS

PROTEIN TRANSLATION SYSTEM

PRIMORDIAL GERM CELLS

PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS

METHOD FOR PREVENTING OR TREATING CANCER BY BLOCKING EXCESSIVE PRODUCTION OF PHOSPHORYLATED VIMENTIN

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO

NANO-IN-MICRO ENCAPSULATED siRNA DRY POWDER, METHOD FOR PRODUCING THE SAME AND USE OF A POWDER FORMULATION

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A))

Antisense oligonucleotides for treatment of USHER 2A. Exons 30-31

METHODS AND COMPOSITIONS RELATED TO TRNA THERAPEUTICS FOR TREATING VISION LOSS

SIGNAL ACTIVATABLE NUCLEIC ACID COMPLEXES

REVERSIR TM COMPOUNDS

METHOD OF REGULATING ALTERNATIVE POLYADENYLATION IN RNA

TARGETED INTRACELLULAR DELIVERY OF LARGE NUCLEIC ACIDS

COMPOSITIONS AND METHODS FOR EXPRESSING FACTOR IX

Modification of Immune Cells to Increase Activity

P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTICS TO THE HEART

CRISPR ENZYMES AND SYSTEMS

CRISPR ENZYMES AND SYSTEMS

MOLECULAR PROGRAMMING TOOLS

DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS

PRIMARY CELL GENE EDITING

CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION

METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS

DOUBLE-STRANDED RNA MOLECULE FOR ADMINISTRATION TO THE EYE

TRANSLATION ENHANCING NUCLEIC ACID COMPOUNDS: ASO COUPLED TRANSLATION – UPREGULATION 1 (ACT-UP1) AND USES THEREOF

PEPTIDE-BASED DELIVERY AGENT WITH ASPARAGINE-CONTAINING MASK PEPTIDE GROUP AND METHOD OF MAKING AND USING THE SAME

MODIFIED OLIGONUCLEOTIDES

PROTOZOA TRANSCRIPTION FACTOR INHIBITOR

GENE SILENCING BY RECOMBINANT AAV-AMIRNA IN ALEXANDER DISEASE

OLIGONUCLEOTIDES CONJUGATES COMPRISING 7'-5'-ALPHA-ANOMERIC-BICYCLIC SUGAR NUCLEOSIDES

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF

SEQUENCE SPECIFIC ANTIMICROBIALS

COMPOSITIONS AND METHODS FOR MUSCLE DISORDERS

APPLICATION BASED ON NUCLEOTIDES OF LACTOBACILLUS RHAMNOSUS TO PREPARE A COMPOSITION FOR ANTI-LIPOGENESIS

LIPID NANOPARTICLES, NUCLEIC ACIDS, AND METHODS OF USE

TYPE I-D CRISPR-GUIDED TRANSPOSON WITH ENHANCED GENOME EDITING

CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND METHODS OF USING SAME

UNIVERSAL NON-TARGETING SIRNA COMPOSITIONS AND METHODS OF USE THEREOF

OVERSUBSCRIPTION SCHEDULING

METHODS OF MODULATING PROGRANULIN EXPRESSION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS

Compounds and Methods for Reducing APOCIII Expression

COMPOSITIONS AND METHODS FOR INHIBITING STAG1 EXPRESSION AND USES THEREOF

Targeting Ligands For Therapeutic Compounds

MAMMALIAN CELL LINE FOR PROTEIN PRODUCTION AND LIBRARY GENERATION

CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF

TETRAZINE AMINO ACIDS AND METHODS FOR THEIR PRODUCTION AND USE

Materials and Methods for Treatment of Hemoglobinopathies

Neuroprotection and Axon Regeneration Therapies for CNS Axonopathies by Modulating Membrane Structure, Cytoskeleton and Signaling Molecules

GLYCAN CONJUGATE COMPOSITIONS AND METHODS

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATION

METHOD OF DELIVERY OF DNA OR RNA CARGO USING UNSHIELDED LIPID NANOPARTICLES AND COMPOSITIONS THEREOF

POLY-GA PROTEINS IN ALZHEIMER’S DISEASE

ENRICHMENT OF ABERRANTLY MODIFIED DNA

METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF

TARGETED TRANS-SPLICING USING CRISPR/CAS13

MULTI-TARGETED SINGLE ENTITY CONJUGATES

PERMANENT EPIGENETIC GENE SILENCING

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING CIDEB

E. COLI NISSLE STRAIN WITH IMPROVED TRANSFORMATION EFFICIENCY

Modified Rhodamine Dye and use Thereof in Biological Assays

GENE THERAPY FOR AUTOSOMAL DOMINANT DISEASES

VECTORS COMBINING ANTI-SICKLING BETA-AS3-GLOBIN WITH ANTI BCEL11A SHRNAMIR TO TREAT BETA-HEMOGLOBINOPATHIES

COMPOSITION FOR INHIBITING METASTASIS AND ENHANCING ANTICANCER DRUG SENSITIVITY

METHODS AND COMPOSITIONS FOR MODIFYING FLOWERING TIME GENES IN PLANTS

METHODS AND SYSTEMS FOR IDENTIFYING AND VALIDATING A GENE COMBINATION ASSOCIATED WITH A TRAIT AND USES THEREOF

GENOME INSERTIONS IN CELLS

PRODUCTION OF VIRAL VECTORS

POLYNUCLEOTIDES FOR MODIFYING ORGANISMS

Use of Trinucleotide Repeat RNAs To Treat Cancer

Methods For The Treatment Of ANGPTL3-Related Diseases And Disorders

NEURAL REPAIR THROUGH INHIBITION OF REG3A SIGNALING

Novel systems for nucleic acid regulation

RNA CIRCULARIZATION

METHODS OF TREATMENT OF GNAQ AND GNA11 DRIVEN DISEASE

METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS

CARBOCYCLIC NUCLEOSIDE, OLIGONUCLEOTIDE AND PREPARATION METHODS THEREFOR AND MEDICAL USES THEREOF

DELIVERY OF HYDROPHOBIC ACTIVE AGENT PARTICLES

GENE THERAPY FOR HAPLOINSUFFICIENCY

INTRACELLULAR TARGETING OF OLIGONUCLEOTIDES

CELLULAR THERAPY

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

COMBINATION OF A GREMLIN-1 ANTAGONIST WITH AN INHIBITOR OF RAS-RAF-MEK-ERK SIGNALLING

COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS

MEASUREMENT OF SOMATIC L1 RETROTRANSPOSITION ACTIVITY

COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID

LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO CNS TISSUE

MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULE, MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDE CONJUGATE, AND USE THEREOF

CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS FOR CIRCULAR RNA AFFINITY PURIFICATION

SYF2 ANTISENSE OLIGONUCLEOTIDES

Nucleic acid regulation of ApoE

Selective Reduction of Allelic Variants

OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES

INITIALIZATION AGENT AND KIT FOR INITIALIZING BLOOD CELLS DERIVED FROM PERIPHERAL BLOOD, AND METHOD FOR INITIALIZING THE SAME

PHARMACEUTICAL COMPOSITION CONTAINING miR-140 AND METHOD FOR PRODUCING SAME

ADENO-ASSOCIATED VIRUS VECTORS FOR NUCLEIC ACID DELIVERY ACROSS RETINAL REGIONS

Lipid Based Nanoparticles for Targeted Gene Delivery to the Brain

IMMUNE CELLS WITH COMBINATION GENE PERTURBATIONS

TARGET SYSTEM FOR HOMOLOGY-DIRECTED REPAIR AND GENE EDITING METHOD USING SAME

COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION

TUNING CASCADE ASSAY KINETICS VIA MOLECULAR DESIGN

Materials and Methods for Treatment of Hemoglobinopathies

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCULAR DYSTROPHIES

SYSTEMS METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING

COMPOSITIONS AND METHODS FOR RECOMBINANT AAV PRODUCTION

TREATING METASTATIC CANCER AND MODEL SYSTEMS FOR METASTATIC DISEASE

ADENO-ASSOCIATED VIRUS VECTORS FOR NUCLEIC ACID DELIVERY TO RETINAL GANGLION CELLS AND/OR RETINAL PIGMENT EPITHELIUM CELLS

MODIFIED RNAi AGENTS

NANOMATERIALS COMPRISING TRIOLS

RECOMBINANT YEAST CELL

COMPOUNDS AND COMPOSITIONS INCLUDING PHOSPHOROTHIOATED OLIGODEOXYNUCLEOTIDE, AND METHODS OF USE THEREOF

Use of Non-Coding Nucleic Acid for Crop Improvement and Protection Against Microbes

CONSTRUCTS, VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING LONG NONCODING RNA ANRIL FOR TREATMENT OF DISEASE

ASYMMETRIC RNA MOLECULES

MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT

Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis

METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

POLYNUCLEOTIDE AGENTS TARGETING COMPLEMENT COMPONENT C5 AND METHODS OF USE THEREOF

PHYTOECDYSONES AND/OR 20-HYDROXYECDYSONE DERIVATIVES IN COMBINATION WITH AN ACTIVE INGREDIENT FOR RESTORING SMN EXPRESSION, FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY

COMPOSITION FOR PREVENTING OR TREATING MYOCARDITIS, COMPRISING VLA-4 INHIBITOR

USE OF IRE1ALPHA-XBP1 SIGNALING PATHWAY BIOMARKERS FOR MODULATING IMMUNE RESPONSES

CRY PROTEIN CRYSTALS AND METHODS OF USE

BIOLOGICAL POLYMERS

LIPID NANOPARTICLES

MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT

THERAPEUTIC VESICLES AND METHODS OF PROCESSING THE SAME

GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY

ARTIFICIAL microRNAs TARGETING TAU

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF ALPHA-1 ANTITRYPSIN

COMPOSITIONS AND USES FOR TREATMENT THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

RNAi Agents of Modulating PLP1

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF FOR EXON SKIPPING

METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE

TYPE II CAS PROTEINS AND APPLICATIONS THEREOF

SIRNA TARGETING ANGIOTENSINOGEN AND PHARMACEUTICAL USE OF SIRNA

LIPID NANOPARTICLES USED TO TRANSPORT NUCLEIC ACIDS INTO LYMPHATIC ENDOTHELIUM CELLS

S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME

METHODS AND COMPOSITIONS FOR TREATING TNNT2 RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR

GENE AUGMENTATION THERAPIES FOR INHERITED RETINAL DEGENERATION CAUSED BY MUTATIONS IN THE PRPF31 GENE

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER CONJUGATES

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

IMMUNE MODULATORY PARACRINE ACTING CELLS (IMPACS)

GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY

GENE EXPRESSION REGULATOR, AGENT FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE AND METHOD FOR IMPROVING DEMENTIA

LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE, KIT CONTAINING LIPID PARTICLE, AND ACTIVE AGENT DELIVERY METHOD USING LIPID PARTICLE

METHODS FOR IDENTIFYING THERAPEUTIC AGENTS

PRODUCTION OF CIRCULAR POLYRIBONUCLEOTIDES IN A PROKARYOTIC SYSTEM

TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS

MULTIPLEXING TARGETING LIGANDS THROUGH CLICK CHEMISTRY AT THE ANOMERIC SITE OF SUGARS

CANCER STEM CELL MARKER AND CANCER STEM CELL TARGETING DRUG

Methods and Compositions for Treatment of Polycystic Kidney Disease

POLYNUCLEIC ACID MOLECULES TARGETING APOC3 AND USES THEREOF

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF LP(A), PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

ANTISENSE OLIGONUCLEOTIDES FOR TARGETING PROGRANULIN

METHODS OF TREATING OSMIDROSIS

CHIMERIC RNA-DRIVEN GENOMIC REARRANGEMENT IN MAMMALIAN CELLS

Antisense Nucleic Acids

FULLY STABILIZED ASYMMETRIC SIRNA

COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLIOBLASTOMA BY INHIBITION OF THE TFPI2-CD51-STAT6 SIGNALING AXIS

HIGH MOBILITY GROUP BOX-1 (HMGB1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

LIPOPHILIC OLIGONUCLEOTIDE CONJUGATES

SIGNAL ACTIVATABLE NUCLEIC ACID CONSTRUCTS WITH WOBBLE BASE PAIRINGS

CONDITIONALLY ACTIVATABLE NUCLEIC ACID COMPLEXES

ENHANCING ESTROGEN RECEPTOR ALPHA IN OSTEOARTHRITIS

USING DREADD FOR NEURONAL MODULATION IN TREATING NEURONAL DISEASES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

BLOCK COPOLYMERS

Treatment Methods for Fibrosis Targeting SMOC2

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

SUPRAMOLECULAR IONIZABLE LIPID MOLECULES WITH HETEROATOMIC TUNING FOR NUCLEIC ACID DELIVERY

RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES

RIBOZYME-ENHANCED RNA TRANS-SPLICING

COMPOUNDS AND METHODS FOR MODULATING SMN2

COMPOSITIONS OF MODIFIED TREMS AND USES THEREOF

ATXN2 RNA INTERFERENCE AGENTS

METHODS OF TREATING GLAUCOMA

SYSTEMS

SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

HETERONUCLEIC ACID INCLUDING 2'-MODIFIED NUCLEOSIDE

ACTIVE TARGETING MICRORNA OLIGONUCLEOTIDE THERAPEUTICS FOR THE TREATMENT OF CARDIO-METABOLIC DISEASES

METHODS AND CONTROL COMPOSITIONS FOR SEQUENCING

DIRECT REPLACEMENT GENOME EDITING

INHIBITION OF DNA POLYMERASES BY URACIL-DNA GLYCOSYLASE-CLEAVABLE OLIGONUCLEOTIDE LIGANDS

COMBINATION THERAPY FOR TREATMENT OF DISEASE

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

CELL-PENETRATING PEPTIDE CONJUGATES AND METHODS OF THEIR USE

G ALPHA Q/11 INHIBITORS FOR USE AS AN ANALGESIC

COMPOSITIONS AND METHODS FOR THE TREATMENT OF EXPANDED REPEAT-ASSOCIATED DISORDERS

TARGETING PTCHD1 AND NEURONAL CHOLESTEROL TO ENHANCE SAFETY OF OPIOID ANALGESICS

HIF-1 ACTIVATORS AND USES THEREOF

Materials and Methods for Treatment of Hemoglobinopathies

Linear DNA with Enhanced Resistance Against Exonucleases

SMALL RNA-BASED DRUG, PREPARATION AND USE THEREOF IN PROPHYLAXIS AND/OR TREATMENT OF CARDIOMYOPATHY

ANTISENSE OLIGOMERS AND METHODS OF USING THE SAME FOR TREATING DISEASES ASSOCIATED WITH THE ACID ALPHA-GLUCOSIDASE GENE

Treatments of Disorders of Myelin

Microtubule Associated Protein Tau (MAPT) iRNA Agent Compositions and Methods of Use Thereof

NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY

VARIANT ALICYCLOBACILLUS CAS12b PROTEINS WITH IMPROVED DNA CLEAVAGE SELECTIVITY AND METHODS OF USE

PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

GENE THERAPEUTICS FOR TREATING BONE DISORDERS

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC POLYNUCLEOTIDES FOR EXON SKIPPING

COMPOSITIONS AND METHODS FOR ORGAN-PROTECTIVE EXPRESSION AND MODULATION OF CODING RIBONUCLEIC ACIDS

INHIBIN SUBUNIT BETA E INHIBITOR AND METHODS OF USE THEREOF

METHODS FOR IMMUNOREGULATION BY MODULATING PLASMINOGEN-APPLE-NEMATODE (PAN) DOMAIN-CONTAINING PROTEINS

NOVEL SYNTHETIC PROMOTER, AND METHOD FOR PRODUCING DAPTOMYCIN USING SAME

TARGETED GENE EDITING PLATFORM INDEPENDENT OF DNA DOUBLE STRAND BREAK AND USES THEREOF

INTRON FRAGMENTS

COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID

Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128

THERAPEUTIC COMPOSITIONS FOR TREATING PAIN VIA MULTIPLE TARGETS

Brush polymer-oligonucleotide conjugates for the treatment of muscular dystrophy

COMPOSITIONS AND METHODS FOR IMPROVING STRAND BIASED

ACTIVATION OF NONCODING HOST GENE LOCI

Therapeutic Inhibition of LPA Expression

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

USE OF miR-34b IN REGULATING LIPID METABOLISM OF SHANDONG BLACK CATTLE

COMPOSITION FOR PREVENTION OR TREATMENT OF LIVER CANCER, COMPRISING MODIFIED RT-LET7 AS ACTIVE INGREDIENT

COMPOSITIONS AND METHODS FOR TREATING AIRWAY MUCUS DYSFUNCTION

CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF

METHODS OF GENERATING A POPULATION OF NEURONS FROM HUMAN GLIAL PROGENITOR CELLS AND GENETIC CONSTRUCTS FOR CARRYING OUT SUCH METHODS

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY

TRIMERIC PEPTIDES FOR ANTISENSE DELIVERY

COMPOUND FOR INHIBITING C3 GENE EXPRESSION, PHARMACEUTICAL COMPOSITION AND USE THEREOF

MODIFIED IMMUNE CELLS FOR TREATING AND/OR PREVENTING METASTASIS

DESIGN AND DEVELOPMENT OF A NOVEL MESSENGER RNA THERAPEUTIC TO TREAT ATHEROSCLEROSIS

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING

PLANT REGULATORY ELEMENTS AND USES THEREOF

CELL-SPECIFIC EXPRESSION OF modRNA

METHODS AND COMPOSITIONS FOR ACTIVATING TRANSLATION

MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

EFFECTOR PROTEINS AND METHODS OF USE

TREATMENT FOR NUCLEOTIDE REPEAT EXPANSION DISEASE

GENETICALLY-MODIFIED IMMUNE CELLS COMPRISING A MICRORNA-ADAPTED SHRNA (SHRNAMIR)

T-CELLS FOR ANTI-HIV CAR-T THERAPY AND METHODS OF USE

BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE

MATERIALS AND METHODS FOR THE TREATMENT OF LIMB GIRDLE MUSCULAR DYSTROPHY

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

NUCLEIC ACID DELIVERY MATERIAL